Featured Article
U.K. startup Nucleome has raised £37.5 million to further its explorations into how dark matter in the human genome can deliver precision medicines.
Precision Oncology Today
Magazine
Twinning is Winning
As healthcare increasingly becomes informed by the analysis—via machine learning and artificial intelligence—of patient-specific, or disease-specific data, a new tool is steadily making its way onto the scene: patient digital twins. Digital twin technology promises to impact precision medicine from clinical trials to clinical care—in silico.
Translating the Microbiome
A flurry of microbiome research over the past two decades has led to many insights about the link between the microbes and health, but now the race to the clinic is on. Our understanding of the microbiome has been greatly advanced thanks to the improvements in next-generation sequencing techniques.
Trending on Inside Precision Medicine
Magazine Post 8
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Maecenas sed enim ut sem...
Magazine Post 7
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Maecenas sed enim ut sem...